Editorial Commentary: Injections for Knee Osteoarthritis: Doc, You Gotta Help Me!

Arthroscopy. 2021 Apr;37(4):1288-1289. doi: 10.1016/j.arthro.2020.12.228.


Injections for the pain caused by knee osteoarthritis have been the focus of significant research for the last few decades. Systematic reviews and meta-analyses suggest that platelet-rich plasma (PRP) can provide up to 12 months of pain relief in these patients, superior to both cortisone and hyaluronic acid. There is also some evidence for a synergistic effect when combining both PRP and hyaluronic acid. Bone marrow aspirate concentrate (BMAC) has significantly greater levels of interleukin-1ra than PRP, as well as a small concentration of mesenchymal stromal cells. However, BMAC is yet unproven in its efficacy, and obtaining BMAC is not as simple as taking blood. Research into the use of expanded autologous and allogenic mesenchymal stem cells continues and shows future promise. For today, PRP remains the gold standard for the treatment of pain associated with knee osteoarthritis.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Hyaluronic Acid
  • Injections, Intra-Articular
  • Osteoarthritis, Knee* / therapy
  • Pain
  • Platelet-Rich Plasma*
  • Treatment Outcome


  • Hyaluronic Acid